P

Pfizer

Makes cancer drugs, vaccines and other medicines

Senior Manager - Chargeback and Pricing Operations

Corporate Finance & FP&AConfirmed live in the last 24 hours
Full-timeHybrid

About the Job

Requirements

  • A bachelor's degree in Finance, Accounting, Economics, or a related field and at least 6 years of experience; or a master's degree and at least 5 years of experience; or a PhD and at least 1 year of experience.
  • Experience in pharmaceutical gross-to-net, revenue deductions, pricing analytics, or commercial finance.
  • Deep working knowledge of pharmaceutical gross-to-net and deduction structures, including chargebacks, rebates, group purchasing organization administrative fees, 340B, Medicaid, and other pricing and contracting impacts.
  • Strong understanding of accrual accounting principles and revenue recognition requirements, including U.S. GAAP and ASC 606, and how gross-to-net activity affects revenue recognition and financial reporting.
  • Demonstrated experience with generic pharmaceutical and/or hospital injectable businesses, including group purchasing organization contracting, chargeback processes, and their effects on gross-to-net, revenue, and profitability.
  • Strong financial modeling and data skills, including advanced Excel and comfort working with large transactional datasets.
  • Ability to translate complex financial impacts into clear, actionable guidance for non-finance commercial partners.
  • Ability to travel to support business needs, stated as less than 10–15%.
  • Must be authorized to be employed in the United States by any employer and have permanent work authorization in the United States.

Responsibilities

  • Provide analytics to inform gross-to-net assumptions, focusing on contracting and chargebacks, and advise stakeholders on the effects of 340B, Medicaid, and other gross-to-net drivers on revenue and profitability.
  • Support chargeback accrual pipeline calculations and related analytics using Finance- and Controllership-approved methodologies and assumptions.
  • Analyze contracting activity, claims, utilization, pricing trends, and other commercial data to identify emerging trends and assess potential impacts on gross-to-net and revenue forecasts.
  • Compare commercial assumptions with actual experience, identify variance drivers, and provide business rationale and analytics to support forecast refinement and decision-making.
  • Partner with Finance, Controllership, and Commercial stakeholders to provide data, insights, and business context for gross-to-net forecasting, accrual assessment, reconciliation, and financial reporting.
  • Partner with Finance to inform gross-to-net forecasts with commercial assumptions, analytics, and insights related to contracting, chargebacks, payer/channel mix, pricing actions, and new product launches.
  • Provide commercial gross-to-net inputs and business rationale for Finance forecasting and planning cycles, including budget, latest estimates, reforecasts, and long-range planning.
  • Model the gross-to-net, revenue, and profitability impacts of contracting strategies, including bids, committed contracts, off-cycle price actions, channel strategies, and business development initiatives, to inform decisions before they are finalized.
  • Develop what-if scenarios and key-driver sensitivities to assess the potential impact of contracting changes, market dynamics, and legislative changes, and translate results into actionable insights for Commercial and Finance stakeholders.
  • Serve as functional owner of the commercial revenue and demand data repository, ensuring its architecture supports gross-to-net calculations and forecasting outputs.
  • Ensure data integrity between the Flex contract management system and the corporate ERP; optimize use of chargeback and script-level data and third-party aggregators to improve rebate validation and forecast accuracy.
  • Drive automation, scalable dashboards, and reporting improvements using AI-enabled tools responsibly, with appropriate governance and human oversight, to shift capacity toward insight generation.
  • Serve as a key liaison between PCO and Finance, translating commercial strategies and contracting activities into financial implications while aligning with financial reporting, accounting, and control requirements.
  • Partner with PCO on pre-deal analytics to align contracting and pricing assumptions to forecasts, and feed executed-deal outcomes back to improve future forecasts.
  • Coordinate gross-to-net data collection and assumption refresh across Business Analytics, Contract Operations, Government Pricing, Distribution, Finance, and Accounting.
  • Assist in list price calculations and impact analytics for wholesaler price adjustments (clawbacks), shelf stock adjustments, and related activities.
  • Partner with the finance business partner on Government Pricing and Compliance accrual implications for Medicaid (MDRP), 340B, and FSS/FCP; understand and explain government pricing calculations, including AMP, Best Price, non-FAMP, unit rebate amount, and 340B ceiling price.
  • Support business-specific pricing governance, including financial evaluation of contracting decisions and performance against original gross-to-net projections, while coordinating with broader Pfizer pricing governance requirements and timelines.
  • Develop and coach others, and oversee and guide colleagues' work to achieve outcomes and business impact.

Desired Qualifications

  • Experience with hospital, injectable, or biosimilar portfolios and group purchasing organization/integrated delivery network contracting dynamics.
  • Familiarity with government pricing programs, including MDRP, 340B, and FSS/FCP.
  • Experience with revenue management/gross-to-net systems such as Model N and Revitas/Flex, and ERP systems such as SAP or Oracle.
  • Proficiency in business intelligence tools such as Power BI or Tableau, and experience building reporting infrastructure and automating processes from the ground up.
  • MBA, CPA, or CMA.

About the Company

Pfizer

Makes cancer drugs, vaccines and other medicines

Pfizer discovers, makes, and sells prescription medicines and vaccines for patients, doctors, and governments worldwide, with large businesses in vaccines, cancer, heart disease, and rare diseases. In 2020, its COVID-19 shot, developed with German partner BioNTech, became the first COVID-19 vaccine authorized in the United States. Its scientists find drug candidates and run clinical trials to prove they are safe and effective, and Pfizer then manufactures approved products in its own plants, earning most of its money from patented drugs before cheaper generic copies arrive. Pfizer was founded in 1849 as a chemicals business in Brooklyn and is based in New York City.

Company size
10,001+
Company stage
IPO
Headquarters
New York City, New York
Founded
1849

Recently Posted Jobs

Explore more opportunities at Pfizer

See more jobs